Seminars in Oncology
Volume 35, Issue 1 , Pages 7-10 , February 2008

Defining the Clinical Diagnosis of Inflammatory Breast Cancer

  • S. Eva Singletary

      Affiliations

    • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
    • Corresponding Author InformationAddress correspondence to S. Eva Singletary, MD, FACS, Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 444 Houston, TX 77030-4095.
    • ,
  • Massimo Cristofanilli

      Affiliations

    • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

References 

  1. Bozzetti F, Saccozzi R, De Lena M, et al. Inflammatory cancer of the breast: analysis of 114 cases. J Surg Oncol. 1981;18:355–361
  2. Barker JL, Nelson AJ, Montague ED. Inflammatory carcinoma of the breast. Radiology. 1976;121:173–176
  3. Zucali R, Uslenghi C, Kenda R, et al. Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy. Cancer. 1976;37:1422–1431
  4. Bell C. A system of operative surgery. Hartford, CT: Hale & Hosmer; 1814;
  5. Hance KW, Anderson SF, Deves SS, et al. Trends in inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results Program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966–975
  6. Walshe JM, Swain SM. Clinical aspects of inflammatory breast cancer. Breast Dis. 2005/06;22:35–44
  7. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed.. New York: Springer; 2002;
  8. Kushwaha AC, Whitman GJ, Stelling CB, et al. Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. Am J Roentgenol. 2000;174:535–538
  9. Bonnier P, Charpin C, Lejeune C, et al. Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?. Int J Cancer. 1995;62:382–385
  10. Ellis DI, Teitelbaum SL. Inflammatory carcinoma of the breast (A pathologic definition). Cancer. 1974;33:1045–1047
  11. Saltzstein S. Clinically occult inflammatory carcinoma of the breast. Cancer. 1974;34:382–388
  12. Lucas FV, Perez-Mesa C. Inflammatory carcinoma of the breast. Cancer. 1978;41:1595–1605
  13. Levine PH, Steinborn SC, Ries LG, Aron JL. Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) program. J Natl Cancer Inst. 1985;4:291–297
  14. Taubman KL, McKay MJ. Axillary lymphoma masquerading as inflammatory breast cancer. Biomed Imaging Intervention J. 2006;2:e36;Available online at: http://www.biij.org/2006/3/e36, accessed March 1, 2007
  15. Kleer CG, van Golden KL, Merajver SD. Molecular biology of breast cancer metastasis (Inflammatory breast cancer: clinical syndrome and molecular determinants). Breast Cancer Res. 2000;2:423–429
  16. Liauw SL, Benda RK, Morris CG, et al. Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease. Cancer. 2004;100:920–929
  17. Smoot RL, Koch CA, Degnom AC, et al. A single-center experience with inflammatory breast cancer, 1985-2003. Arch Surg. 2006;141:567–572
  18. Yang WT, Le-Petross HT, Macapiniac H, et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat. 2007;Epub. Jul 26

PII: S0093-7754(07)00235-7

doi: 10.1053/j.seminoncol.2007.11.010

Seminars in Oncology
Volume 35, Issue 1 , Pages 7-10 , February 2008

Article Tools

* Image Usage & Resolution